4.7 Article

Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial

Related references

Note: Only part of the references are listed.
Article Rheumatology

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study

Atul Deodhar et al.

Summary: The study demonstrates that secukinumab 150 mg provides significant and sustained improvement in patients with active nonradiographic axial spondyloarthritis (SpA) through 52 weeks. The safety profile is consistent with previous reports.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

Heel pain in psoriatic arthropathy: Analysis of a series of 291 patients

Isabel Morales Ivorra et al.

REUMATOLOGIA CLINICA (2018)

Review Rheumatology

Enthesitis: from pathophysiology to treatment

Georg Schett et al.

NATURE REVIEWS RHEUMATOLOGY (2017)

Article Medicine, General & Internal

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Rheumatology

Metabolic syndrome associated to non-inflammatory Achilles enthesopathy

Michele Abate et al.

CLINICAL RHEUMATOLOGY (2014)

Article Pharmacology & Pharmacy

Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches

Peter Lane

PHARMACEUTICAL STATISTICS (2008)

Article Rheumatology

Quality of life in patients with ankylosing spondylitis:: a pilot study

Yasemin Turan et al.

RHEUMATOLOGY INTERNATIONAL (2007)

Review Nursing

Pain: a review of three commonly used pain rating scales

A Williamson et al.

JOURNAL OF CLINICAL NURSING (2005)

Article Sport Sciences

Heel pain - plantar fasciitis and Achilles enthesopathy

SK Williams et al.

CLINICS IN SPORTS MEDICINE (2004)